Bharat Bio Consortium Gets $14m Grant for Chikungunya Vaccine

In a statement, Bharat Bio said CEPI will fund the consortium for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news